As the Biotech hub of the world, Europe is fertile ground for disruptive research set to transform women’s
health innovation. But how do we champion early-stage clinical development and research and better
translate it into outcomes? How can research and development be better incubated and accelerated?
What strategies should be adopted to ensure that life science innovation and therapeutic solutions are
being prioritized? What are large pharmaceutical companies looking for, and what are some examples
partnerships in the space? Join this opening discussion to unpack these questions, and hearing from
examples of partnerships responsible for leading the way.
Marco Rüedi, Mentor, Tech4Eva, Senior Business Coach,EPFL Innovation Park
Trine Bartholdy, Chief Innovation Officer, BioInnovation Institute
Marco Rüedi, MD
Marco is Entrepreneur, Coach and Trainer in the Swiss Start-up ecosystem with 20+ years international experience in strategic and operational roles across the LifeScience Industry and Healthcare Management.
He is a strong believer in well-balanced teams: motivated to challenge the status quo! Passionate to work with the next generation of Entrepreneurs/Managers for the challenges of tomorrow. He focused on Start-up and Innovation Management, Translational medicine. His motto is “From idea to market”.
He holds a Medical Doctor from the University of Fribourg, Berne and Zurich, an Executive Masters in Medical Management from eMMM PHW Bern, and an Executive Masters in Business Administration from eMBA PHW Bern.
